Lv4
610 积分 2022-02-16 加入
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
9天前
已完结
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
2个月前
已完结
Detecting residual disease after neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: The prospective multicentre preSINO trial
2个月前
已完结
Patients' preferences for treatment after neoadjuvant chemoradiotherapy for oesophageal cancer
3个月前
已完结
Oesophageal cancer
4个月前
已完结
Is there still a place for radiotherapy in gastric cancer?
6个月前
已完结
[18F]AlF-NOTA-FAPI-04 PET/CT for Predicting Pathologic Response of Resectable Esophageal Squamous Cell Carcinoma to Neoadjuvant Camrelizumab and Chemotherapy: A Phase II Clinical Trial
6个月前
已完结
Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trial
6个月前
已完结
From neoadjuvant to organ-sparing immunotherapy for colorectal cancer
7个月前
已完结
Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial
7个月前
已完结
皖公网安备34019202002308
